Gongwin Biopharm Holdings Co., Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was TWD 1.15 million. Net loss was TWD 42.14 million compared to TWD 89.21 million a year ago.

Basic loss per share from continuing operations was TWD 0.37 compared to TWD 0.81 a year ago.